Biocon Biologics, 5% 8jan2026, INR (Conv.) (FIGI BBG00YHPDM62, INE597V08018)
国内債券, 転換社債, Interest at Maturity, Senior Unsecured
国内債券, 転換社債, Interest at Maturity, Senior Unsecured
|
Biocon Biologics is engaged in developing high quality, affordable biosimilars that can expand access to a cutting-edge class of therapies to patients globally. It is is a subsidiary of Biocon Limited. Biocon Biologics was incorporated on ...
Biocon Biologics is engaged in developing high quality, affordable biosimilars that can expand access to a cutting-edge class of therapies to patients globally. It is is a subsidiary of Biocon Limited. Biocon Biologics was incorporated on 8 June, 20176 and is located in Bangalore, India.
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡